| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00 |
Summary
A vulnerability labeled as problematic has been found in IBM Sametime 8.5.1/9.0. The affected element is an unknown function. Executing a manipulation can lead to information disclosure. This vulnerability is tracked as CVE-2016-2966. The attack can be launched remotely. No exploit exists.
Details
A vulnerability was found in IBM Sametime 8.5.1/9.0. It has been declared as problematic. This vulnerability affects an unknown part. The manipulation with an unknown input leads to a information disclosure vulnerability. The CWE definition for the vulnerability is CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. As an impact it is known to affect confidentiality. CVE summarizes:
IBM Sametime 8.5.1 and 9.0 could allow an authenticated user to enumerate meeting rooms by guessing the meeting room id. IBM X-Force ID: 113847.
The bug was discovered 08/25/2017. The weakness was disclosed 08/29/2017 (Website). The advisory is shared for download at ibm.com. This vulnerability was named CVE-2016-2966 since 03/09/2016. The attack can be initiated remotely. A single authentication is necessary for exploitation. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 01/10/2021). It is expected to see the exploit prices for this product increasing in the near future.The MITRE ATT&CK project declares the attack technique as T1592.
The vulnerability was handled as a non-public zero-day exploit for at least 4 days. During that time the estimated underground price was around $5k-$25k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at SecurityFocus (BID 100572†). The entries VDB-105887, VDB-105890, VDB-105893 and VDB-105899 are pretty similar. Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.3
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 4.3
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Information disclosureCWE: CWE-200 / CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
03/09/2016 🔍08/25/2017 🔍
08/25/2017 🔍
08/29/2017 🔍
08/29/2017 🔍
08/30/2017 🔍
01/10/2021 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2016-2966 (🔍)
GCVE (CVE): GCVE-0-2016-2966
GCVE (VulDB): GCVE-100-105892
X-Force: 113847
SecurityFocus: 100572 - IBM Sametime Proxy Server Multiple Security Vulnerabilities
See also: 🔍
Entry
Created: 08/30/2017 08:25Updated: 01/10/2021 09:00
Changes: 08/30/2017 08:25 (54), 11/11/2019 13:33 (10), 01/10/2021 09:00 (2)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.